Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Carcinoma, Non-Small-Cell Lung 3Pancreatic Neoplasms 2Colorectal Neoplasms 2Stomach Neoplasms 1Rhabdomyosarcoma 1Neuroectodermal Tumors 1Neoplasms 1Neoplasm Metastasis 1NSCLC 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Fanconi Anemia 1Esophageal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

repotrectinib 1pralsetinib 1pamiparib 1Vincristine 1Temozolomide 1Radiotherapy 1Radiation 1Maintenance Chemotherapy 1Lomustine 1Interleukin-12 1Cisplatin 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Neuroectodermal Tumors × Afatinib × Clear all
NCT02372006 2021-03-04

Trial of Afatinib in Pediatric Tumours

Boehringer Ingelheim

Phase 1/2 Completed
56 enrolled 23 charts
Sarcoma

Rhabdomyosarcoma, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡